- CEO
- Yi Wang
- Full Time Employees
- 6,224
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- No. 1 Tongce Medical Building Hangzhou ZH China 310023
- IPO Date
- Oct 30, 1996
- Business
- Topchoice Medical Corporation operates primarily in the healthcare sector, specializing in dental, assisted reproductive, and ophthalmological medical services. The company offers a comprehensive range of dental healthcare services, including dental implants, orthodontics, pediatric dentistry, periodontics, endodontics, and cosmetic dentistry, delivered through a network of approximately 32 dental hospitals across China. It integrates advanced technologies such as digital dentistry, CAD/CAM systems, 3D printing for prosthetics, intraoral scanners, and CBCT imaging to enhance diagnostic accuracy and treatment outcomes. In assisted reproductive services, the company provides in-vitro fertilization (IVF), fertility preservation, and related treatments, utilizing cutting-edge techniques like preimplantation genetic testing (PGT) and advanced sperm selection methods. Ophthalmology services encompass diagnosis, treatment, and surgical solutions for cataracts, refractive errors, glaucoma, and retinal diseases, employing technologies including optical coherence tomography (OCT) and femtosecond lasers. Topchoice Medical also engages in medical equipment sales, daily necessities, disinfection products, and investment management.
Founded in 1995 and headquartered in Hangzhou, China, Topchoice Medical serves primarily the Chinese market through its specialized clinics, contributing significantly to the privatized healthcare sector. The company emphasizes quality and innovation by adopting advanced medical technologies and practices to improve patient care and outcomes.
Recent major developments include the acquisition of a 6% stake in Zhejiang Topchoice Eye Hospital Investment Management Co., Ltd., reflecting expansion in the ophthalmological segment, and a strategic equity buyback plan totaling CNY 50 million approved in 2024. The firm is actively expanding its network of dental and medical aesthetic clinics while integrating telemedicine services to enhance accessibility. It also focuses on research and development in dental technologies and reproductive medicine, including AI-assisted diagnostics and treatments. These moves align with its strategic goal to broaden its service offerings and deepen technological integration within its core healthcare segments over the last two years.
These activities position Topchoice Medical as a growing leader in China's healthcare services industry, with a strong foothold in dental, reproductive, and ophthalmology markets, supported by innovation and strategic expansion initiatives.